3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Prostatic Neoplasms
1
Papillomavirus Infections
1
Papilloma
1
Leiomyoma
1
Inflammation
1
Frailty
1
Interventions
Exercise
5
Vitamin D
2
Tea
2
Sufentanil
2
Spironolactone
2
Probiotics
2
Oxycodone
2
Omeprazole
2
Morphine
2
Metformin
2
Etanercept
2
Colchicine
2
Ascorbic Acid
2
ziprasidone
1
soybean oil, phospholipid emulsion
1
salicylsalicylic acid
1
ginger extract
1
falcarinol
1
falcarindiol
1
epigallocatechin gallate
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Tumor Necrosis Factors
1
Tranexamic Acid
1
Tobramycin
1
Sulindac
1
Sodium Salicylate
1
Sodium Chloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Inflammation
×
epigallocatechin gallate
×
Clear all
NCT04553666
2026-05-07
ReFOCUS1
University of Rochester
Phase 2
Completed
24 enrolled
17 charts